Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History

Investment Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$683K	Hold	1,389	–	–	0.24%	88
2025 Q4	$805K	Buy	1,389 +1	+0.1%	+$566	0.28%	79
2025 Q3	$673K	Hold	1,388	–	–	0.24%	89
2025 Q2	$563K	Hold	1,388	–	–	0.21%	92
2025 Q1	$690K	Buy	1,388 +91	+7%	+$49.3K	0.29%	80
2024 Q4	$675K	Sell	1,297 -200	-13%	-$110K	0.28%	82
2024 Q3	$926K	Hold	1,497	–	–	0.39%	64
2024 Q2	$828K	Hold	1,497	–	–	0.37%	65
2024 Q1	$870K	Hold	1,497	–	–	0.39%	67
2023 Q4	$794K	Sell	1,497 -99	-6%	-$47.9K	0.39%	68
2023 Q3	$808K	Hold	1,596	–	–	0.43%	66
2023 Q2	$833K	Sell	1,596 -50	-3%	-$27K	0.43%	62
2023 Q1	$949K	Sell	1,646 -93	-5%	-$52.4K	0.5%	59
2022 Q4	$958K	Sell	1,739 -1,142	-40%	-$605K	0.51%	61
2022 Q3	$1.46M	Buy	2,881 +1,143	+66%	+$640K	0.43%	69
2022 Q2	$944K	Hold	1,738	–	–	0.46%	59
2022 Q1	$1.03M	Hold	1,738	–	–	0.43%	59
2021 Q4	$1.16M	Buy	1,738 +500	+40%	+$312K	0.47%	48
2021 Q3	$707K	Buy	1,238 +1	+0.1%	+$549	0.32%	72
2021 Q2	$624K	Hold	1,237	–	–	0.28%	74
2021 Q1	$565K	Hold	1,237	–	–	0.27%	75
2020 Q4	$576K	Hold	1,237	–	–	0.31%	71
2020 Q3	$546K	Hold	1,237	–	–	0.33%	72
2020 Q2	$448K	Buy	1,237 +1	+0.1%	+$335	0.26%	79
2020 Q1	$351K	Sell	1,236 -150	-11%	-$47.3K	0.25%	81
2019 Q4	$450K	Hold	1,386	–	–	0.3%	75
2019 Q3	$404K	Buy	1,386 +180	+15%	+$51.5K	0.29%	77
2019 Q2	$354K	Sell	1,206 -279	-19%	-$76.8K	0.25%	84
2019 Q1	$407K	Hold	1,485	–	–	0.29%	78
2018 Q4	$332K	Buy	+1,485	New	+$348K	0.28%	81
2018 Q3	–	Sell	-1,485	Closed	-$308K	–	161
2018 Q2	$308K	Hold	1,485	–	–	0.23%	93
2018 Q1	$307K	Hold	1,485	–	–	0.23%	102
2017 Q4	$282K	Hold	1,485	–	–	0.21%	112
2017 Q3	$281K	Hold	1,485	–	–	0.24%	94
2017 Q2	$259K	Sell	1,485 -99	-6%	-$16.6K	0.24%	97
2017 Q1	$243K	Hold	1,584	–	–	0.23%	97
2016 Q4	$224K	Sell	1,584 -1,888	-54%	-$278K	0.22%	99
2016 Q3	$552K	Buy	3,472 +1,888	+119%	+$291K	0.31%	87
2016 Q2	$234K	Sell	1,584 -1,887	-54%	-$279K	0.23%	99
2016 Q1	$492K	Buy	3,471 +1,887	+119%	+$253K	0.32%	86
2015 Q4	$225K	Buy	+1,584	New	+$211K	0.27%	88
2015 Q3	–	Sell	-1,583	Closed	-$205K	–	98
2015 Q2	$205K	Hold	1,583	–	–	0.25%	90
2015 Q1	$213K	Hold	1,583	–	–	0.23%	89
2014 Q4	$200K	Buy	+1,583	New	+$192K	0.23%	91

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Investment Partners's TMO Position: Q1 2026 in Review

Investment Partners held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 1,389 shares worth $683K. The position accounts for 0.24% of the portfolio, ranked #88.

Investment Partners first reported a position in TMO in Q4 2014 and has held it in 44 quarters since. The position peaked at $1.46M in Q3 2022. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Investment Partners held 1,389 shares of Thermo Fisher Scientific worth $683K as of Q1 2026.
Investment Partners left its Thermo Fisher Scientific share count unchanged in Q1 2026.
Thermo Fisher Scientific made up 0.24% of Investment Partners's portfolio in Q1 2026, its #88 holding.
Investment Partners first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 44 quarters since.
Investment Partners's Thermo Fisher Scientific position peaked at $1.46M in Q3 2022.
2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Investment Partners's 13F filing for Q1 2026, filed 5 May 2026.